Example: confidence
Search results with tag "Igpro20"
The PATH study - CIDP Treatment With Subcutaneous ...
www.gbs-cidp.org1 Hizentra CIDP (PATH) – IgPro20_3003 K. Goodwin 21 Nov. 2012 The PATH study - CIDP Treatment With Subcutaneous Immunoglobulin (IgPro20) CSL Behring is currently recruiting patients for the PATH study, an international clinical